These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2516083)

  • 41. Ceftazidime (GR 20263), a new cephalosporin derivative with excellent activity against Pseudomonas and Enterobacteriaceae.
    Chattopadhyay B; Hall I; Curnow SR
    J Antimicrob Chemother; 1981 Dec; 8(6):491-3. PubMed ID: 6801002
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.
    Tzouvelekis LS; Prinarakis EE; Gazouli M; Miriagou V; Tzelepi E; Legakis NJ
    Chemotherapy; 1996; 42(5):324-8. PubMed ID: 8874970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In-vitro and in-vivo antibacterial activities of E1040, a new cephalosporin with potent antipseudomonal activity.
    Hiruma R; Otsuki M; Tashima M; Obana Y; Nishino T
    J Antimicrob Chemother; 1990 Dec; 26(6):769-81. PubMed ID: 2127928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [In vitro study of antibacterial activity of cefepime (Axepim) against gram negative bacteria: comparison with cephalosporins and other beta-lactams].
    Vachée A; Devalckenaere A; Husson MO; Izard D
    Pathol Biol (Paris); 1996 Feb; 44(2):132-7. PubMed ID: 8761598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime.
    Campo Esquisabel AB; Rodríguez MC; Campo-Sosa AO; Rodríguez C; Martínez-Martínez L
    Clin Microbiol Infect; 2011 Dec; 17(12):1817-22. PubMed ID: 21599797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.
    Berrazeg M; Jeannot K; Ntsogo Enguéné VY; Broutin I; Loeffert S; Fournier D; Plésiat P
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6248-55. PubMed ID: 26248364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics.
    Gargalianos P; Oppenheim BA; Skepastianos P; Livermore DM; Williams RJ
    J Antimicrob Chemother; 1988 Dec; 22(6):841-8. PubMed ID: 3149631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
    Alatoom A; Elsayed H; Lawlor K; AbdelWareth L; El-Lababidi R; Cardona L; Mooty M; Bonilla MF; Nusair A; Mirza I
    Int J Infect Dis; 2017 Sep; 62():39-43. PubMed ID: 28610832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of four methods for the determination of the susceptibility of 47 strains of Pseudomonas aeruginosa to ceftazidime and cefepime: influence of the choice of interpretative criteria].
    Boucaud-Maître Y; Thoinet S
    Pathol Biol (Paris); 1996 May; 44(5):363-6. PubMed ID: 8758477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters.
    Mushtaq S; Warner M; Livermore DM
    J Antimicrob Chemother; 2010 Nov; 65(11):2376-81. PubMed ID: 20801783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
    Bell JM; Turnidge JD;
    Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria.
    Livermore DM; Mushtaq S; Warner M; Vickers A; Woodford N
    J Antimicrob Chemother; 2017 May; 72(5):1373-1385. PubMed ID: 28158732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
    Inoue K; Inoue E; Mitsuhashi S
    Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of subinhibitory concentrations of cephalosporins on the serum sensitivity of Pseudomonas aeruginosa.
    Darveau RP; Cunningham MD
    J Infect Dis; 1990 Oct; 162(4):914-21. PubMed ID: 2119402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of drug resistance. The beta-lactamases of gram-negative bacteria including pseudomonads.
    Richmond MH; Jack GW; Sykes RB
    Ann N Y Acad Sci; 1971 Jun; 182():243-57. PubMed ID: 4998885
    [No Abstract]   [Full Text] [Related]  

  • 58. Activity of cefepime against resistant strains of Pseudomonas aeruginosa.
    Talon D; Thouverez M; Mulin B
    J Antimicrob Chemother; 1997 Dec; 40(6):909-10. PubMed ID: 9462449
    [No Abstract]   [Full Text] [Related]  

  • 59. Isolation and properties of beta-lactamase-less mutants from clinically important gram-negative bacteria.
    Ohmori H; Azuma A; Suzuki Y; Hashimoto Y
    J Antibiot (Tokyo); 1977 Mar; 30(3):267-9. PubMed ID: 405358
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative in vitro evaluation of cefpimizole (U-63196E), a new antipseudomonal cephalosporin.
    LeFrock JL; Smith BR; Bihl J
    Antimicrob Agents Chemother; 1985 Jul; 28(1):133-7. PubMed ID: 3929676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.